<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:admin="http://webns.net/mvcb/"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Sciencemission &amp; : Posters</title>
<link>https://sciencemission.com/rss/category/posters</link>
<description>Sciencemission &amp; : Posters</description>
<dc:language>en</dc:language>
<dc:rights>Copyright 2023 Sciencemission&amp; All Rights Reserved.</dc:rights>

<item>
<title>DEVELOPMENTAL THERAPEUTICS—MOLECULARLY TARGETED AGENTS AND TUMOR BIOLOGY</title>
<link>https://sciencemission.com/developmental-therapeuticsmolecularly-targeted-agents-and-tumor-biology</link>
<guid>https://sciencemission.com/developmental-therapeuticsmolecularly-targeted-agents-and-tumor-biology</guid>
<description><![CDATA[ First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in
patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following
enzalutamide (ENZ) and/or abiraterone (ABI).Read more... ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202406/image_870x580_665f13345d9a5.jpg" length="76203" type="image/jpeg"/>
<pubDate>Tue, 21 May 2024 06:32:20 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>DEVELOPMENTAL THERAPEUTICS—IMMUNOTHERAPY</title>
<link>https://sciencemission.com/developmental-therapeuticsimmunotherapy</link>
<guid>https://sciencemission.com/developmental-therapeuticsimmunotherapy</guid>
<description><![CDATA[ Pilot study on outcome and antitumor efficacy of an autologous cancer cell vaccine
applied in patients with advanced solid tumors.
Eglys Gonzalez Marcano, Leona Kr  ̈ohle, Joachim Ahlers, Joachim Drevs; UniFontis, Sickte, Germany;
Unifontis, Sickte, Germany; UniFontis, Koln, Germany Read more... ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202406/image_870x580_665f139166aa8.jpg" length="67964" type="image/jpeg"/>
<pubDate>Tue, 21 May 2024 06:29:50 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>GASTROINTESTINAL CANCER—COLORECTAL AND ANAL</title>
<link>https://sciencemission.com/gastrointestinal-cancercolorectal-and-anal</link>
<guid>https://sciencemission.com/gastrointestinal-cancercolorectal-and-anal</guid>
<description><![CDATA[ A phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd; DS-8201) in

patients (pts) with HER2-expressing metastatic colorectal cancer (mCRC): DESTINY-
CRC01.Read more... ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202406/image_870x580_665f1416baf0c.jpg" length="90216" type="image/jpeg"/>
<pubDate>Tue, 21 May 2024 06:26:15 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>GYNECOLOGIC CANCER</title>
<link>https://sciencemission.com/gynecologic-cancer</link>
<guid>https://sciencemission.com/gynecologic-cancer</guid>
<description><![CDATA[ Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in
recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20.Read more.... ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202406/image_870x580_665f1454b61f2.jpg" length="68830" type="image/jpeg"/>
<pubDate>Tue, 21 May 2024 06:23:02 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>GENITOURINARY CANCER—PROSTATE, TESTICULAR, AND PENILE</title>
<link>https://sciencemission.com/genitourinary-cancerprostate-testicular-and-penile</link>
<guid>https://sciencemission.com/genitourinary-cancerprostate-testicular-and-penile</guid>
<description><![CDATA[ TheraP: A randomised phase II trial of 177Lu-PSMA-617 (LuPSMA) theranostic versus
cabazitaxel in metastatic castration resistant prostate cancer (mCRPC) progressing after
docetaxel: Initial results (ANZUP protocol 1603).Read more.. ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202406/image_870x580_665f149c65b13.jpg" length="92684" type="image/jpeg"/>
<pubDate>Tue, 21 May 2024 06:20:13 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>GENITOURINARY CANCER—KIDNEY AND BLADDER</title>
<link>https://sciencemission.com/genitourinary-cancerkidney-and-bladder</link>
<guid>https://sciencemission.com/genitourinary-cancerkidney-and-bladder</guid>
<description><![CDATA[ IMvigor010: Primary analysis from a phase III randomized study of adjuvant atezolizumab
(atezo) versus observation (obs) in high-risk muscle-invasive urothelial carcinoma
(MIUC).Read more... ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202406/image_870x580_665f14dc1ffa8.jpg" length="71494" type="image/jpeg"/>
<pubDate>Tue, 21 May 2024 06:16:16 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>HEAD AND NECK CANCER</title>
<link>https://sciencemission.com/head-and-neck-cancer</link>
<guid>https://sciencemission.com/head-and-neck-cancer</guid>
<description><![CDATA[ Transoral robotic surgical resection followed by randomization to low- or standard-dose
IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN
Cancer Research Group (E3311).Read more... ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202406/image_870x580_665f152193407.jpg" length="89198" type="image/jpeg"/>
<pubDate>Tue, 21 May 2024 06:12:30 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT</title>
<link>https://sciencemission.com/health-services-research-and-quality-improvement</link>
<guid>https://sciencemission.com/health-services-research-and-quality-improvement</guid>
<description><![CDATA[ The oncology hospital at home: Health care utilization outcomes from the huntsman at
home trial.
Kathi Mooney, Karen Titchener, Benjamin Haaland, Lorinda Adaire Coombs, Brock O Neil,
Richard Nelson, Jordan P. McPherson, Anne C. Kirchhoff, Karen Ameloot, Anna Catherine Beck,
John Harris Ward; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; University of Utah,
Salt Lake City, UT Read more ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202406/image_870x580_665f15764822c.jpg" length="98661" type="image/jpeg"/>
<pubDate>Tue, 21 May 2024 06:07:54 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Single&amp;molecule covalent magnetic tweezers</title>
<link>https://sciencemission.com/single-molecule-covalent-magnetic-tweezers</link>
<guid>https://sciencemission.com/single-molecule-covalent-magnetic-tweezers</guid>
<description><![CDATA[ 1Department of Biological Sciences, Ashoka University, Sonepat, Haryana 131029, India
2Department of Chemistry, Ashoka University, Sonepat, Haryana 131029, India
3.Trivedi School of Biosciences, Ashoka University, Sonepat, Haryana 131029, India ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202405/image_870x580_664aded972cf5.jpg" length="86027" type="image/jpeg"/>
<pubDate>Sat, 18 May 2024 11:54:13 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>A chemical biology/modular antibody platform for ADP&amp;ribosylation signaling</title>
<link>https://sciencemission.com/a-chemical-biologymodular-antibody-platform-for-adp-ribosylation-signaling</link>
<guid>https://sciencemission.com/a-chemical-biologymodular-antibody-platform-for-adp-ribosylation-signaling</guid>
<description><![CDATA[ Research Group of Proteomics and ADP-ribosylation Signaling, Max Planck Institute for Biology of Ageing, 50931 Cologne, Germany 2 Cologne Excellence Cluster for Stress Responses in Ageing-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany 3 These authors contributed equally to this work.Read more ]]></description>
<enclosure url="http://sciencemission.com/uploads/images/202406/image_870x580_665f15c655f16.jpg" length="66765" type="image/jpeg"/>
<pubDate>Sat, 18 May 2024 11:30:40 -0400</pubDate>
<dc:creator>nikita</dc:creator>
<media:keywords></media:keywords>
</item>

</channel>
</rss>